Zyvox (linezolid), a potent new antibiotic for gram-positive infections

May 2000

The FDA just approved Zyvox (linezolid), a potent new antibiotic for gram-positive infections.

Zyvox is the first in a new class...the oxazolidinones.

It will be used for serious gram-positive infections...including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote